001     147393
005     20240229112649.0
024 7 _ |a 10.3174/ajnr.A6286
|2 doi
024 7 _ |a pmid:31649159
|2 pmid
024 7 _ |a 0195-6108
|2 ISSN
024 7 _ |a 1936-959X
|2 ISSN
024 7 _ |a altmetric:69437930
|2 altmetric
037 _ _ |a DKFZ-2019-02510
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Stock, A.
|b 0
245 _ _ |a Imaging Characteristics of Wingless Pathway Subgroup Medulloblastomas: Results from the German HIT/SIOP-Trial Cohort.
260 _ _ |a Oak Brook, Ill.
|c 2019
|b Soc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1577094642_18928
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 40(11):1811-1817
520 _ _ |a In addition to the 4 histopathologically defined entities of medulloblastoma, 4 distinct genetically defined subgroups have been included in the World Health Organization classification of 2016. The smallest subgroup is the medulloblastoma with activated wingless pathway. The goal of this study was to identify a typical MR imaging morphology in a larger number of pediatric patients with wingless pathway medulloblastoma.From January 2001 to October 2017, of 75 patients with histologically confirmed and molecularly subgrouped wingless pathway medulloblastomas recruited to the German Pediatric Brain Tumor (HIT) trials, 38 patients (median age, 12.8 ± 4.6 years at diagnosis; 24 [63.2%] female) had preoperative imaging that passed the entry criteria for this study. Images were rated by the local standardized imaging criteria of the National Reference Center of Neuroradiology. Additionally, a modified laterality score was used to determine tumor localization and extension.Twenty-eight of 38 (73.7%) were primary midline tumors but with a lateral tendency in 39.3%. One extensively eccentric midline tumor was rated by the laterality score as in an off-midline position. Five tumors were found in the cerebellopontine angle; 3, in the deep white matter; and 2, in a cerebellar hemisphere. Leptomeningeal dissemination was rare (11.5%). In 60.5%, intratumoral blood-degradation products were found, and 26.3% showed cysts with blood contents.According to our observations, wingless pathway medulloblastomas are not preferentially off-midline tumors as postulated in previous studies with smaller wingless pathway medulloblastoma cohorts. Dense intratumoral blood-degradation products and cysts with blood contents are frequently found and might help to differentiate wingless pathway medulloblastoma from other medulloblastoma subtypes.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Mynarek, M.
|0 0000-0003-3302-2719
|b 1
700 1 _ |a Pietsch, T.
|0 0000-0002-9252-8923
|b 2
700 1 _ |a Pfister, S. M.
|0 0000-0002-5447-5322
|b 3
700 1 _ |a Clifford, S. C.
|0 0000-0002-8573-8009
|b 4
700 1 _ |a Goschzik, T.
|0 0000-0002-3487-6508
|b 5
700 1 _ |a Sturm, D.
|0 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
|b 6
|u dkfz
700 1 _ |a Schwalbe, E. C.
|0 0000-0002-1190-9469
|b 7
700 1 _ |a Hicks, D.
|0 0000-0002-7551-7464
|b 8
700 1 _ |a Rutkowski, S.
|0 0000-0002-5446-9571
|b 9
700 1 _ |a Bison, B.
|0 0000-0001-5849-8671
|b 10
700 1 _ |a Pham, M.
|0 0000-0003-1295-2685
|b 11
700 1 _ |a Warmuth-Metz, M.
|0 0000-0002-3544-319X
|b 12
773 _ _ |a 10.3174/ajnr.A6286
|g p. ajnr;ajnr.A6286v1
|0 PERI:(DE-600)2025541-X
|n 11
|p 1811-1817
|t American journal of neuroradiology
|v 40
|y 2019
|x 1936-959X
909 C O |p VDB
|o oai:inrepo02.dkfz.de:147393
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 0000-0002-5447-5322
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 6
|6 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b AM J NEURORADIOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21